Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Yong Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6508-508X; OpenAlex author ID A5025468453. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer. Last author DOI 10.1038/s41598-023-43174-y↗
  2. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08769-6↗
  3. Analysis of 300 consecutive cases of pancreatic adenocarcinoma in a single-center in China. First author DOI 10.1016/s1499-3872(16)60066-8↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baolin Qian · 1 shared paper, 2023 · strength 0.18
  2. Xiangyan Jiang · 1 shared paper, 2021 · strength 0.13
  3. Zeyuan Yu · 1 shared paper, 2021 · strength 0.13
  4. Hongbin Li · 1 shared paper, 2021 · strength 0.13
  5. Bei Sun · 1 shared paper, 2016 · strength 0.06
  6. Hongchi Jiang · 1 shared paper, 2016 · strength 0.06
  7. Lianxin Liu · 1 shared paper, 2016 · strength 0.06
  8. Han Lin · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.